Sort by
Refine Your Search
-
Overview Our goal is to harness the therapeutic use of stem cells to repair neuronal damage in the brain. It is our hypothesis that neuroprotective factors that are naturally present in our body
-
About Us The School of Science and Technology at Nottingham Trent University (NTU) is an exciting multidisciplinary environment for learning, teaching and research, with some of the best facilities in the UK. We pride ourselves on delivering high-quality teaching and diverse, real-world...
-
About the Role We are inviting applications for an enthusiastic researcher to investigate sensory neurodegeneration within the Centre for Systems Health and Integrated Metabolic Research. Modern day
-
, the hair follicle, HF). Skin serves as an important source of adult stem cells (SCs) required for formation and regeneration of the skin and HF during post-natal life has the remarkable regenerative capacity
-
. This research programme will identify key MAMs influencing cancer cell survival and investigate any influence on chemotherapeutic response and other relevant stressors (e.g. hypoxia). Transcriptomic changes and
-
that AML cells evade the immune system and that their genetic “make-up” can help clinicians predict response to chemotherapy, a direct form of attack on rapidly dividing cancer cells, and to immunotherapy
-
understanding, and difficulties in carrying out daily tasks. The science is straightforward but devastating: the human brain is composed of billions of connected nerve cells – conditions like Alzheimer’s block
-
the ingestion of spores which require certain primary BAs in order to germinate into the vegetative cells that multiply and produce the disease-causing exotoxins, TcdA and TcdB. In contrast, secondary BAs
-
6.0 in each component. Candidates with previous laboratory experience, particularly microbiology, cell culture (including 3D cell culture models and bioinformatics are encouraged to apply. In
-
42mer PAP-derived peptide. The project will build upon the data generated to date by demonstrating the ability of vaccine-induced T-cells to slow-down/inhibit the growth of human prostate cancer cells and